TLR4 and metabolic dysfunction-associated steatohepatitis: Interestingly, Sharifnia et al. 13 observed up‐regulated TLR4 expression in liver, elevated plasma FFAs as well as lipopolysaccharide (LPS) in a large cohort of obese human patients with NASH, suggesting a positive feedback regulation of TLR4.